MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR CANCER THERAPY
CY1125907T1Undetermined Publication Date: 2026-04-17TRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIV MAINZ GEMEINNUETZIGE GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100153T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2007-05-29
- Filing Date
- 2023-03-20
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-03-20
Abstract
The present invention provides antibodies useful as therapeutics for the treatment and / or prevention of diseases associated with cells expressing CLD18, including diseases associated with tumors such as stomach cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, liver cancer, head and neck cancer, and gallbladder cancer and their metastases.
Need to check novelty before this filing date? Find Prior Art